Advertisement
Covidien
Subscribe to Covidien
View Sample

FREE Email Newsletter

Covidien Unveils Innovative Capnography Solution for OEM Partners

May 9, 2013 10:16 am | by Covidien | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, has launched the Microstream® MicroPod™ module. This is an important product for its Original Equipment Manufacturer (OEM) partners that will help hospitals improve patient safety by expanding access to capnography technology.

Recall: Covidien pulls ventilator batteries amid defect concerns

April 19, 2013 3:54 pm | by Mass Device | News | Comments

Massachusetts-based medical device maker Covidien announced a voluntary recall of certain Power Pac batteries distributed with its Newport HT70 and HT70 Plus ventilators, according to an FDA notice. Covidien launched the recall in response to reports that some batteries were resorting to back-up power sooner than expected while operating on the Power Pac battery.

Covidien Awarded $176.5M in Patent Lawsuit

March 29, 2013 2:36 pm | by The Associated Press | News | Comments

Irish drug and medical device maker Covidien said Friday that a federal court in Connecticut has awarded it $176.5 million after ruling that a Johnson & Johnson unit infringed on three of its ultrasonic surgical products patents. The lawsuit against J&J's Ethicon Endo-Surgery Inc. was...

Advertisement

Covidien Awarded $176.5 Million Verdict in Patent Litigation against Ethicon Endo-Surgery

March 29, 2013 12:54 pm | by The Associated Press | News | Comments

NEW HAVEN, Conn.--(BUSINESS WIRE)--Mar 29, 2013--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has won a patent infringement suit against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, relating to Ethicon's Harmonic® line of...

Covidien Closes Enrollment in Iliac Stent Studies

February 21, 2013 11:38 am | by Mass Device | News | Comments

Covidien said it closed enrollment in a pair of its Visibility and Durability iliac stent clinical studies. The prospective, multinational studies are designed to compare balloon stents with self-expanding stents in the iliac arteries for treating peripheral artery disease.

Two-Year Clinical Study Supports Safety and Efficacy of Covidien Revascularization Device

February 7, 2013 6:42 pm | by The Associated Press | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Feb 7, 2013--Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) study. The two-year study evaluated the safety and efficacy of the Solitaire FR...

Covidien Supports Centers for Medicare & Medicaid Services Quality Measure #3040

January 21, 2013 9:24 am | by Covidien | News | Comments

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announces its support for the Centers of Medicare & Medicaid Services (CMS) proposed quality measure #3040, currently considered for a Medicare program rule. Quality measures help CMS assess performance of hospitals participating...

Covidien Announces FDA 510(k) Clearance and CE Mark for Nellcor Bedside Respiratory Patient Monitoring System

October 4, 2012 11:25 am | by Covidien | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced U.S. Food and Drug Administration 510(k) clearance and European Economic Area (EEA) CE Mark approval for the Covidien Nellcor™ Bedside Respiratory Patient Monitoring system.

Advertisement

M&A: The top 15 acquirers among medical device companies

August 6, 2012 3:37 pm | by Mass Device | News | Comments

A look at the most acquisitive medical device companies, culled from MassDevice.com's Big 100 database of more than 1,300 medical device industry transactions. More than $50 billion was spent on acquisitions by Big 100 medical device companies from the beginning of 2011 through the 1st half of 2012.

Covidien Announces Global Launch of Nellcor SpO2 Module for Philips IntelliVue Patient Monitors

June 25, 2012 6:11 am | News | Comments

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced the launch of its Nellcor™ SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform.

Covidien launches new device for colorectal surgery

June 1, 2012 2:32 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Medical device maker Covidien (NYSE: COV) has launched a new stapler to be used in colorectal surgery. The New Haven, Conn. office of the Mansfield-based company developed the Radial Reload device based on its GIA Radial Reload with Tri-Staple technology with the feedback Covidien...

Covidien and GE Healthcare Form Five-Year Collaboration

May 3, 2012 5:26 am | News | Comments

Covidien and GE Healthcare, leading global providers of healthcare products and recognized innovators in patient monitoring and respiratory care devices, today announced a five-year, global collaboration to incorporate Covidien measurement technologies into GE Healthcare...

Covidien Completes Acquisition of Newport Medical Instruments, Inc.

May 2, 2012 6:31 am | News | Comments

Covidien plc, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that it has completed the previously announced acquisition of Newport Medical Instruments, Inc. for an aggregate...

Advertisement

Covidien Announces Definitive Agreement to Acquire Oridion Systems Ltd.

April 5, 2012 5:08 am | News | Comments

Dublin, Ireland – Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive agreement to acquire Oridion Systems Ltd.

Covidien Prevails in Patent Action against Applied Medical Resources

April 4, 2012 5:32 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, announced that it has prevailed against Applied Medical Resources Corp. in a patent action before the U.S. District Court, Central District of California.

Covidien Announces Organizational Changes

March 30, 2012 6:09 am | News | Comments

MANSFIELD, Mass. - Covidien, a leading global provider of healthcare products, today announced organizational changes to the leadership team of its Vascular Therapies Global Business Unit. According to Stacy Enxing Seng, president of the 4,000 employee, $1.4 billion business...

Covidien Announces Definitive Agreement to Acquire Newport Medical Instruments

March 23, 2012 10:31 am | News | Comments

DUBLIN--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced a definitive agreement to acquire Newport Medical Instruments, Inc. Covidien will acquire...

Covidien Revascularization Device Receives FDA Clearance

March 6, 2012 4:52 am | News | Comments

Covidien, a leading global provider of healthcare products, today announced that the Solitaireâ„¢ FR revascularization device has been cleared by the U.S. Food and Drug Administration. The Solitaire FR device is intended to restore blood flow to the brain in patients suffering acute ischemic stroke by mechanically removing blood clots from blocked vessels.

Covidien Revascularization Device Approved for Interventional Management of Stroke Trial

January 31, 2012 6:01 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that the Solitaireâ„¢ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial. The Solitaire FR...

Reverse Medical Corporation Announces Sale of its Neurovascular Guide Catheter Business

January 26, 2012 5:58 am | News | Comments

IRVINE, Calif.--(BUSINESS WIRE)--Reverse Medical Corporation today announced that it has sold its line of neurovascular guide catheters to Covidien, a leading global provider of healthcare products. The terms of the transaction were not disclosed. “Despite being a young company...

Covidien CEO Elected Chairman of the Board

January 23, 2012 5:33 am | News | Comments

DUBLIN--(BUSINESS WIRE)--Covidien plc today announced that its Board of Directors has elected President and Chief Executive Officer José E. Almeida to the additional position of Chairman of the Board, effective March 13, 2012. Mr. Almeida will succeed...

Covidien Provides Update on Voluntary Recall of BIS Bilateral Sensors

January 20, 2012 5:10 am | News | Comments

BOULDER, Colo.--(BUSINESS WIRE)--On November 8, 2011, Covidien initiated a voluntary recall of certain lots of its BISâ„¢ Bilateral Sensors, due to a modification which inadvertently reversed the reference and left eye electrode. This modification could potentially cause a change...

Covidien Contraindicates the Use of Duet TRS for Thoracic Surgery, Implements a Voluntary Recall

January 17, 2012 4:49 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that it is conducting a voluntary recall of all production lots for the Duet TRSTM Universal Straight and Articulating Single Use Loading Units...

Covidien Announces CE Mark for Nellcor Respiration Rate Software

December 21, 2011 6:17 am | News | Comments

BOULDER, Colo.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced it will label the Covidien Nellcorâ„¢ Respiration Rate Version 1.0 Software and...

Covidien's Embolic Protection Device Receives FDA Clearance

December 2, 2011 4:35 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX® for the treatment of severely calcified lesions used in conjunction with plaque excision...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading